Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

RemeGen Co., Ltd. (REGMF)

Compare
1.5000
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,076,130
1,076,130
767,775
1,423,902
--
Cost of Revenue
253,136
253,136
269,939
67,163
--
Gross Profit
822,994
822,994
497,836
1,356,739
--
Operating Expense
2,325,340
2,325,340
1,551,915
1,053,655
637,242
Operating Income
-1,502,346
-1,502,346
-1,054,079
303,084
-637,242
Net Non Operating Interest Income Expense
5,052
5,052
54,786
38,025
-27,571
Pretax Income
-1,511,229
-1,511,229
-998,830
276,258
-697,821
Net Income Common Stockholders
-1,511,229
-1,511,229
-998,830
276,258
-697,821
Diluted NI Available to Com Stockholders
-1,511,229
-1,511,229
-998,830
276,258
-697,821
Basic EPS
-2.80
-2.80
-1.88
0.57
-1.71
Diluted EPS
-2.80
-2.80
-1.88
0.57
-1.71
Basic Average Shares
538,914.2300
538,914.2300
530,120.1370
487,443.3010
408,148.5480
Diluted Average Shares
539,873.3900
539,873.3900
531,154.5440
487,443.3010
408,148.5480
Total Expenses
2,578,476
2,578,476
1,821,854
1,120,818
637,242
Net Income from Continuing & Discontinued Operation
-1,511,229
-1,511,229
-998,830
276,258
-697,821
Normalized Income
-1,506,977
-1,506,977
-999,823
276,599
-697,779
Interest Income
28,143
28,143
61,543
43,348
1,655
Interest Expense
23,091
23,091
6,757
5,323
29,226
Net Interest Income
5,052
5,052
54,786
38,025
-27,571
EBIT
-1,488,138
-1,488,138
-992,073
281,581
-668,595
EBITDA
-1,247,859
-1,247,859
-805,702
402,053
-590,929
Reconciled Cost of Revenue
253,136
253,136
269,939
67,163
--
Reconciled Depreciation
240,279
240,279
186,371
120,472
77,666
Net Income from Continuing Operation Net Minority Interest
-1,511,229
-1,511,229
-998,830
276,258
-697,821
Total Unusual Items Excluding Goodwill
-4,252
-4,252
993
-341
-42
Total Unusual Items
-4,252
-4,252
993
-341
-42
Normalized EBITDA
-1,243,607
-1,243,607
-806,695
402,394
-590,887
12/31/2020 - 1/21/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BPMC Blueprint Medicines Corporation
81.68
-6.23%
 
LEGN Legend Biotech Corporation
32.01
-2.65%
 
BMRN BioMarin Pharmaceutical Inc.
60.26
-10.70%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5300
-5.94%
 
BHVN Biohaven Ltd.
18.59
-9.54%
 
SLNO Soleno Therapeutics, Inc.
67.48
-6.49%
 
CYTK Cytokinetics, Incorporated
37.36
-7.80%
 
SMMT Summit Therapeutics Inc.
17.36
-8.20%
 
REGN Regeneron Pharmaceuticals, Inc.
573.45
-6.09%